Women whose 21-SNP panel result indicated they were at high risk of obesity were less likely to respond to exercise by losing weight or body fat.
Researchers identified low-frequency lung cancer risk variants through a three-stage association involving nearly 13,000 Chinese individuals.
The company attributed the revenue growth to the strong performance of its genotyping and reproductive health business.
Arrayit also alleged that the actions of an investor suing the company threatens a company contract with the US Department of Agriculture.
While it may be dominating the market in terms of sales, some industry observers believe that AncestryDNA has work to do before it can challenge the quality of services offered by its rivals.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.